Trademark: 90244179
Word

Status
Pending
Status Code
651
Status Date
Sunday, March 10, 2024
Serial Number
90244179
Mark Type
2000
Filing Date
Friday, October 9, 2020

Trademark Owner History

Classifications
36 Financial sponsorship of clinical and translational trials in the field of cancer treatment
35 Promoting collaboration and the exchange of information and resources within the scientific, research, medical, clinical and private communities to achieve advances in the field of cancer treatment; Providing pharmacoeconomic information in the nature of medical and/or research data pertaining to cancer and its treatment
44 Providing medical information featuring profiles of cancer patients' tumours and the associated clinical and molecular data, and medical information pertaining to cancer drugs, biomarkers, biological and tissue samples, and results of clinical studies, via an on-line searchable database; providing tissue biobank services, namely, access to a biobank of human biological and tissue samples; providing medical information concerning quality of life in the fields of the treatment of cancer, the likelihood of success of the treatment of cancer, the physical and psychological impacts of the treatment of cancer on patients and the recovery time from the treatment of cancer; providing medical information in the nature of medical data pertaining to cancer and its treatment; providing psychosocial care information in the nature of medical data pertaining to cancer and its treatment; providing medical information about pharmacovigilance in the nature of medical data pertaining to cancer and its treatment; providing medical information pertaining to cancer and its treatment
42 Medical and scientific research in the field of molecular profiling and biomarker discovery in cancer patients; medical and scientific research in the field of cancer treatment; providing research information in the nature of medical research data pertaining to cancer and its treatment; conducting translational trials for others in the field of cancer treatment, consisting of a combination of clinical research and scientific research; conducting trials in the field of cancer treatment for others; providing clinical trial information in the nature of medical and scientific research data pertaining to cancer; providing medical research information pertaining to cancer and its treatment
The mark consists of a stylized depiction of a DNA double helix.

Trademark Events
Mar 10, 2024
Notification Of Inquiry As To Suspension E-Mailed
Mar 10, 2024
Inquiry To Suspension E-Mailed
Mar 10, 2024
Suspension Inquiry Written
Feb 5, 2024
Suspension Checked - To Attorney For Action
Jul 15, 2023
Notification Of Letter Of Suspension E-Mailed
Jul 15, 2023
Letter Of Suspension E-Mailed
Jul 15, 2023
Suspension Letter Written
Apr 21, 2023
Teas/Email Correspondence Entered
Apr 21, 2023
Correspondence Received In Law Office
Apr 20, 2023
Assigned To Lie
Apr 12, 2023
Teas Response To Suspension Inquiry Received
Jan 27, 2023
Notification Of Inquiry As To Suspension E-Mailed
Jan 27, 2023
Inquiry To Suspension E-Mailed
Jan 27, 2023
Suspension Inquiry Written
Jul 15, 2022
Notification Of Letter Of Suspension E-Mailed
Jul 15, 2022
Letter Of Suspension E-Mailed
Jul 15, 2022
Suspension Letter Written
Jun 2, 2022
Teas/Email Correspondence Entered
Jun 2, 2022
Correspondence Received In Law Office
May 28, 2022
Assigned To Lie
May 25, 2022
Teas Response To Suspension Inquiry Received
Nov 28, 2021
Notification Of Inquiry As To Suspension E-Mailed
Nov 28, 2021
Inquiry To Suspension E-Mailed
Nov 28, 2021
Suspension Inquiry Written
Oct 27, 2021
Suspension Checked - To Attorney For Action
Apr 19, 2021
Notification Of Letter Of Suspension E-Mailed
Apr 19, 2021
Letter Of Suspension E-Mailed
Apr 19, 2021
Suspension Letter Written
Mar 12, 2021
Teas/Email Correspondence Entered
Mar 11, 2021
Correspondence Received In Law Office
Mar 11, 2021
Teas Response To Office Action Received
Feb 25, 2021
Notification Of Non-Final Action E-Mailed
Feb 25, 2021
Non-Final Action E-Mailed
Feb 25, 2021
Non-Final Action Written
Feb 24, 2021
Assigned To Examiner
Nov 25, 2020
Notice Of Design Search Code E-Mailed
Nov 24, 2020
New Application Office Supplied Data Entered
Oct 13, 2020
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24